12 Health Care Stocks Moving In Friday's Pre-Market Session
Portfolio Pulse from Benzinga Insights
In Friday's pre-market session, several healthcare stocks showed significant movement. Revance Therapeutics, Eterna Therapeutics, Connect Biopharma Hldgs, Celularity, Trxade Health, and Windtree Therapeutics were among the gainers, with increases ranging from 12.19% to 16.5%. On the downside, GRI Bio, Sharps Technology, Biofrontera, Kiora Pharmaceuticals, Cadrenal Therapeutics, and Corbus Pharmaceuticals experienced declines between 9.04% and 31.8%.
February 02, 2024 | 1:06 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Corbus Pharmaceuticals stock declined by 9.04% to $25.28, with a market value of $111.8 million.
CRBP's pre-market decline indicates negative market reaction, possibly due to company-specific issues, expected to impact its short-term stock price negatively.
CONFIDENCE 85
IMPORTANCE 75
RELEVANCE 90
NEGATIVE IMPACT
GRI Bio shares fell 31.8% to $1.33 during Friday's pre-market session.
The sharp decline in GRI's stock price suggests negative investor sentiment or adverse news, likely leading to short-term downward price pressure.
CONFIDENCE 85
IMPORTANCE 85
RELEVANCE 90
POSITIVE IMPACT
Eterna Therapeutics shares increased by 15.78% to $1.98, with a market value of $10.7 million.
ERNA's notable pre-market gain indicates a positive market reaction, potentially due to company-specific news, driving short-term bullish sentiment.
CONFIDENCE 85
IMPORTANCE 75
RELEVANCE 90
POSITIVE IMPACT
Revance Therapeutics shares surged 16.5% to $6.0, with a market cap of $526.8 million.
The significant pre-market increase in RVNC's stock price suggests positive investor sentiment or reaction to recent news, likely to result in short-term upward price momentum.
CONFIDENCE 85
IMPORTANCE 80
RELEVANCE 90